Cardene In 0.86% Sodium Chloride In Plastic Container

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 14 USDMF, 1 CEP/COS, 1 JDMF, 2 EU WC, 2 KDMF, 7 NDC API, 24 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

77 FDF Dossiers, 48 FDA Orange Book, 14 Europe, 1 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML), INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 8 DKSH, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 4 ACG Worldwide, 2 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 1 CD Formulation, 3 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures, 2 Ingredion Pharma Solutions, 3 Kerry, 1 Keval Exports, 3 Lonza Capsugel, 7 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 28 Roquette, 2 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 Silverline Chemicals, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

40 Fillers, Diluents & Binders, 27 Coating Systems & Additives, 17 Thickeners and Stabilizers, 16 Direct Compression, 15 Taste Masking, 13 Controlled & Modified Release, 13 Film Formers & Plasticizers, 12 Lubricants & Glidants, 11 Co-Processed Excipients, 11 Granulation, 9 Chewable & Orodispersible Aids, 9 Parenteral, 8 Empty Capsules, 7 Disintegrants & Superdisintegrants, 5 Solubilizers, 4 Topical, 4 Emulsifying Agents, 3 Coloring Agents, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers, 1 Soft Gelatin, 1 API Stability Enhancers

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 22 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 5 Regulatory FDF Prices

MARKET PLACE

19 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

22 US Patents, 2 US Exclusivities

REF. STANDARDS & IMPURITIES

1 EDQM, 2 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 19734 / DOSAGE - INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML)

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
NICARDIPINE HYDROCHLORIDE(UNII: K5BC5011K3) (NICARDIPINE - UNII:CZ5312222S)	NICARDIPINE HYDROCHLORIDE	0.1mg in 1 \| 0.1mg in 1

Inactive Ingredients

Ingredient Name	Chiesi USA, Inc.	EKR Therapeutics	EKR Therapeutics, Inc.
CITRIC ACID MONOHYDRATE(2968PHW8QP)
DEXTROSE MONOHYDRATE(LX22YL083G)
SODIUM CHLORIDE(451W47IQ8X)
SODIUM HYDROXIDE(55X04QC32I)
SORBITOL(506T60A25R)

Drug Product Composition: Cardene In 0.86% Sodium Chloride In Plastic Container